Wintzen A R, de Jonge H, Loeliger E A, Bots G T
Ann Neurol. 1984 Nov;16(5):553-8. doi: 10.1002/ana.410160505.
In a retrospective study of 166 patients, all admitted to the University Hospital, Leiden, The Netherlands, between January 1, 1970 and December 31, 1979, we estimated the relative risk of intracerebral hemorrhage from oral anticoagulant therapy. The risk was more than ten times higher for patients over 50 years of age than for similarly aged untreated individuals in the general population. Within this age group the risk was influenced by neither age nor sex. Hypertension, present in 80% of the patients, was the most important predisposing condition; the risk of bleeding rose with increasing intensity of anticoagulation. There was no substantial difference in clinical condition at onset, rate of progression, mortality, or degree of recovery between patients with anticoagulant-associated hemorrhage and those with spontaneous intracranial hemorrhage.
在一项针对166例患者的回顾性研究中,这些患者于1970年1月1日至1979年12月31日期间全部入住荷兰莱顿大学医院,我们评估了口服抗凝治疗引发脑出血的相对风险。50岁以上患者发生脑出血的风险比一般人群中年龄相仿的未接受治疗个体高出十多倍。在这个年龄组中,风险不受年龄和性别的影响。80%的患者患有高血压,这是最重要的诱发因素;出血风险随着抗凝强度的增加而上升。抗凝相关出血患者与自发性颅内出血患者在发病时的临床状况、进展速度、死亡率或恢复程度方面没有实质性差异。